About KTD
Built to connect medical innovation with market opportunity
Established in 2008 and headquartered in Tehran, KTD works at the intersection of science, regulation, and commercial development to support responsible market entry in Iran.
Why KTD exists
Promising medical technologies do not enter a new healthcare market through distribution alone. They require scientific understanding, regulatory planning, credible positioning, and a commercial approach adapted to local conditions.
KTD exists to help bridge these requirements—connecting international medical innovation with healthcare needs and market opportunities in Iran through responsible execution and long-term partnership.
Our role
More than a route to market
-
Scientific Understanding
Evaluating the technology, evidence, clinical context, and positioning required for credible market development.
-
Regulatory Planning
Supporting the definition of an appropriate registration and documentation pathway for the Iranian market.
-
Commercial Development
Developing a market approach shaped by local channels, professional engagement, and long-term product positioning.
-
Partnership Coordination
Bringing scientific, regulatory, and commercial activities into one coordinated relationship with the manufacturer.
Group & network
A connected business and scientific network
KTD operates as part of a broader business group and works through a strategic manufacturing and scientific network. This structure provides access to complementary experience across medical diagnostics, regenerative medicine, professional education, research, and evaluated localization pathways.
Companies, facilities, licenses, and projects within the network may remain legally independent. Their involvement is defined according to the requirements and approved structure of each partnership.
Business areas
Cross-disciplinary perspective
-
Diagnostics
Scientific, regulatory, and commercial understanding of diagnostic technologies and laboratory-market requirements.
-
Regenerative Medicine
Evaluation and market-development support for regenerative and cell-based healthcare technologies within applicable regulatory boundaries.
-
Aesthetic Medicine
Market understanding, professional engagement, and partnership evaluation for evidence-based aesthetic medical technologies.
Geographic focus
Focused on Iran, connected to regional opportunity
Iran is KTD’s primary operational market. Through related business networks, KTD also maintains the capacity to evaluate selected opportunities involving Afghanistan, Iraq, and the UAE.
This regional outlook supports partnership planning without implying broad or established operations across the Middle East.
- Afghanistan
- Iraq
- UAE
Principles
How we work
-
Science before marketing
-
Evidence before claims
-
Partnership before transactions
-
Long-term value before short-term sales
-
Transparency over exaggeration
Start with the market question
If you are evaluating Iran as a potential market for your medical technology, KTD can begin with a structured discussion of the product, evidence, regulatory context, and partnership options.